HCID 178513218, compound → HCID 22125572, compound
Reaction equation
FC(F)(F)C(O)=O.[F:8][C:9]1[C:10]([C:24]([NH:26]O)=[NH:25])=[CH:11][C:12]2[N:16]=[C:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=3)[NH:14][C:13]=2[CH:23]=1>[Zn].C(O)(=O)C>[F:8][C:9]1[C:10]([C:24]([NH2:26])=[NH:25])=[CH:11][C:12]2[N:16]=[C:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=3)[NH:14][C:13]=2[CH:23]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture comprising 6-fluoro-N-hydroxy-2-pyridin-2-yl-1H-benzimidazole-5-carboxamidine trifluoroacetate (108 mg, 0.4 mmol), Zn (55 mg, 1.2 mmol) and acetic acid (5 mL) was heated at reflux under nitrogen for 2 hours. The mixture was filtered and concentrated to dryness. The residue was taken up and purified by preparative reverse phase HPLC. The combined pure fractions were lyophilized to provide 6-fluoro-2-pyridin-2-yl-1H-benzimidazole-5-carboxamidine; MS (ESI), Calculated for C13H10FN5 : 255.09, Found (MH+): 255.9; 1H-NMR (300 Mhz, DMSO-d6): 7.64-7.69 (m, 2H), 7.97 (d, 1H), 8.08 (m, 1H), 8.42 (d, 1H), 8.78 (d, 1H), 8.48 (d, 4H).
Workup
- temperatureat reflux under nitrogen for 2 hours
- filtrationThe mixture was filtered
- concentrationconcentrated to dryness
- custompurified by preparative reverse phase HPLC
Sources & evidence
- ORD record
- ord-6171610637ab44fdb7fe2f4164439443
- Source dataset
- uspto-grants-2000_11
- Patent number
- US06150379
Reaction notes
Loading…